Does insurance cover Ozempic or Wegovy?

Start with your plan's written coverage rules

Having insurance does not mean every GLP-1 or every use is covered. The exact product, diagnosis, benefit exclusions and formulary all matter. Ask your insurer: “Is this medication covered for my prescribed use? What prior authorization criteria apply, and what would I pay?” Request the written policy and keep a reference number for the answer.

If you are comparing cash-pay options, start with GLP-1 without insurance. This guide explains how to understand a coverage decision and choose the next administrative step.

Commercial insurance, Medicaid and Medicare differ

• Employer or Marketplace coverage: check your own plan documents. Two employers can buy different benefits from the same insurer. A drug on a formulary may still have restrictions for a particular use.
• Medicaid: check the current state program and your managed-care plan, if applicable. Do not assume that a diabetes benefit also covers weight management.
• Medicare Part D: coverage depends on the prescribed indication and applicable rules. A study showing benefit does not itself create coverage. For example, the SELECT trial evaluated cardiovascular outcomes³; your clinician still needs to identify an applicable covered use and meet the plan's requirements.

The current Medicare GLP-1 Bridge

CMS's Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027. It provides a $50 monthly copay for eligible beneficiaries in eligible Part D plan types who meet its clinical criteria. It operates outside the regular Part D benefit and payment flow; it is not blanket Medicare coverage for weight-loss medication.⁸

A provider must submit a prior authorization confirming eligibility. Only specified products and weight-management uses qualify. People prescribed a GLP-1 for an indication eligible under regular Part D should use that route instead. Ask the prescriber which pathway applies to your diagnosis and product rather than assuming any GLP-1 prescription qualifies for the Bridge.⁹

Prior authorization is an assessment, not a promise

The prescriber submits information the plan requires before it agrees to cover treatment. Depending on the product and indication, the criteria may include diagnosis, BMI, relevant conditions, previous treatment and ongoing care. Ask for the actual criteria rather than copying a generic BMI threshold from a website.

Trials found substantial average weight loss with semaglutide¹ and greater loss with tirzepatide in a direct comparison². Those findings help explain treatment evidence; they do not establish that you personally meet coverage requirements. PCOS or another diagnosis does not automatically strengthen every request or make a particular GLP-1 a covered treatment for that condition.

Bring your medication list, relevant history, prior treatment records and requested test results. Ask the clinician to correct missing or inaccurate information. A complete request can reduce avoidable follow-up questions, but cannot guarantee approval or a faster decision.

Match the response to the reason for denial

Get the denial letter before paying for another appointment solely to resubmit the same request. Distinguish these situations:

1. 1.Benefit exclusion: the plan does not include this treatment category or use. More evidence of medical need may not change the exclusion. Ask the plan or employer benefits administrator what exception or review route is available.
2. 2.Missing information or clinical criteria: the request lacks documentation or does not meet a listed requirement. Have the prescriber address the specific reason with accurate records.
3. 3.Formulary restriction: the requested product is not preferred or covered. Ask about a clinically appropriate covered alternative or whether a formulary exception is available.

The Zepbound versus Wegovy comparison discusses treatment differences. Coverage is another consideration, but the clinician still needs to decide whether a covered alternative is appropriate.

Appeals and external review have rules and deadlines

Follow the denial letter's instructions for an internal appeal, supporting documents and filing deadline. Ask whether your clinician can submit evidence or act as your representative. Keep copies and confirmation of receipt. HealthCare.gov describes internal appeals and independent external review; the route depends on the plan and decision.⁶

External review is available for eligible denials, including certain decisions involving medical judgment. It does not apply automatically to every benefit exclusion. Read the final denial notice for eligibility, the reviewing organization and the applicable deadline. Medicare and Medicaid have their own appeal procedures. Do not assume an appeal will succeed or use a general deadline instead of the instructions that govern your case.⁷

Compare alternatives while the decision is pending

Novo Nordisk publishes Wegovy savings and coverage resources⁴, and Lilly publishes Zepbound self-pay options⁵. Eligibility restrictions apply; a manufacturer card is not the same as insurance coverage. Ask before paying whether a cash purchase can count toward your plan's deductible or be reimbursed later.

Our Form Health and Noom Med reviews explain care and medication questions to check when considering insurance-focused programs. A service helping with paperwork cannot guarantee approval. If you consider self-pay, use the FMmeds and Ascend Vitality reviews to check current prices, state availability, commitment and refund terms; older rates are not current quotes.

You can also compare lower-cost options and options for moms. Separate the drug bill from membership and consultation fees, and ask how care continues if insurance declines coverage. Some links may earn us a referral commission, at no cost to you.